Controversies in Hepatology: The Experts Analyze Both Sides

頁數：177    裝訂：平裝 　開數：25.5*17.5 　印刷：彩色

Product Description
The field of hepatology is full of controversies and clinical dilemmas. Each day, gastroenterologists and hepatologists are faced with the challenge of making the best evidence-based decision in challenging cases that do not readily lend themselves to an easy answer, even with today’s available medical literature.

Controversies in Hepatology: The Experts Analyze Both Sides is based on the principle of an academic debate. Dr. Donald Jensen is joined by 50 colleagues who present evidence-based arguments for and against 17 key controversial areas in hepatology. Each point-counterpoint is then followed up by a summarization of key points by a leading expert in that topic area.

Some Chapter Topics Include:

--Should living donor liver transplantation be considered in adult acute liver failure?
--Should hepatitis C be treated in patients with chronic kidney disease prior to kidney transplant?
--Resect or observe asymptomatic hepatic adenoma?
--Strictly adhere to the “6-month rule” for recent history of alcohol abuse in potential liver transplant candidates?
--Autoimmune hepatitis: maintenance therapy for all patients or stop treatment after histologic remission?

With concise clinical information to reinforce the point-counterpoint text, Controversies in Hepatology: The Experts Analyze Both Sides will become the go-to resource for teaching and perfecting the important skills required to weigh the evidence and arrive at an outcome.

Contents
SECTION I: ACUTE LIVER DISEASE
Chapter 1: Alcoholic Hepatitis: Pentoxifylline Versus Steroids
Chapter 2: Is N-Acetylcysteine Effective in All Cases of Non-Acetaminophen Acute Liver Failure?
Chapter 3: Should Living Donor Transplantation Be Considered in Adult Acute Liver Failure
SECTION II: CHRONIC HEPATITIS B AND C
Chapter 4: Do All Patients With Chronic Hepatitis B Who Are Treatment Candidates Need an Assessment of Fibrosis?
Chapter 5: Should the Decompensated Hepatitis C Cirrhotic Be Treated With Antiviral Therapy?
Chapter 6: Should Hepatitis C Be Treated in Patients With Chronic Kidney Disease Prior to Kidney Transplant?
Chapter 7: Retransplantation for Severe Recurrent Hepatitis C Virus and Previously Failed Pegylated-Interferon/Ribavirin Therapy
Chapter 8: Does a Sustained Virologic Response at Week 72 Indicate a Cure in Chronic Hepatitis C Virus?
SECTION III: LIVER TUMORS
Chapter 9: Should Living Donor Liver Transplantation Be an Option for Patients With Hepatocellular Carcinoma Beyond the Milan Criteria?
Chapter 10: Resect or Observe Asymptomatic Hepatic Adenoma?
SECTION IV: OTHER CHRONIC LIVER DISEASES AND CIRRHOSIS
Chapter 11: Strictly Adhere to the "6-Month Rule" for Recent History of Alcohol Abuse in Potential Liver Transplant Candidates?
Chapter 12: Should Liver Biopsy Be Performed in All Patients With Nonalcoholic Fatty Liver Disease?
Chapter 13: Should the Hepatic Venous Pressure Gradient Be Sequentially Measured to Monitor Beta-Blocker Therapy in the Prophylaxis of Variceal Hemorrhage?
Chapter 14: Standard Dose or Avoid Ursodiol Therapy in Primary Sclerosing Cholangitis?
Chapter 15: Annual Screening of Primary Sclerosing Cholangitis Patients for Cholangiocarcinoma With Magnetic Resonance Cholangiopancreatography and CA 19-9?
Chapter 16: Lactulose or Rifaximin as First-Line Therapy for Hepatic Encephalopathy?
Chapter 17: Autoimmune Hepatitis: Maintenance Therapy for All Patients or Stop Treatment After Histologic Remission?

Financial Disclosures
Index